A 59-year-old man was admitted to the hospital because of an abdominal mass. The patient drank more than 60 g ethanol/day. He had no history of cirrhosis or other medical disorders. Physical examination revealed a cachectic appearance and a large, hard, non-tender abdominal mass occupying the right upper quadrant and epigastric area with a rich collateral circulation (Fig. 1) . Laboratory data revealed alkaline phosphatase 189 IU/L; AST 59 IU/L; ALT 16 IU/L; GGT 83 IU/L; total serum bilirubin 1.96 mg/dL, alpha fetoprotein 87.6 ng/mL. Hepatitis B and C virus serology were negative. A computed tomography (CT) scan (Fig. 2 ) demonstrated a mass that measured 20 x 17 cm in diameter in the left lobe of the liver. Numerous tortuous vessels, infiltration of the inferior cava vein, and superior mesenteric vein thrombosis were also recognized. (Madrid Vol. 104. N.° 5, pp. 264-265, 2012 
Giant hepatocellular carcinoma
The splenic and portal veins were permeable. A final diagnosis of a moderately differentiated hepatocellular carcinoma (HCC) in a cirrhotic liver was established by fine needle aspiration cytology (Fig. 3) . Due to end-stage of patient (ECOG performace status 3) best supportive care was the only treatment indicated. The patient died two months after diagnosis.
DISCUSSION
A patient with cirrhosis and HCC detected at an end-stage (BCLC-D) is presented. More than 80% of HCC affect cirrhotic patients. Therefore, a strategy of 6-month surveillance with ultrasound would favor an early diagnosis in the asymptomatic phase of disease. A treatment with curative intention is possible during this clinical period, which would carry with it a 5-year survival higher than 80% (1, 2) .
Currently in Spain, more than 40% of HCC are detected casually or by symptoms associated with disease. This fact indicates the need to increase the identification of high-risk patients, who should be introduced into screening programs (3).
